Chavkin C - Search Results

Year	Number of Results
1976	2
1979	1
1980	3
1981	2
1982	4
1983	4
1984	1
1985	3
1986	4
1987	1
1988	3
1989	4
1990	5
1991	5
1992	5
1993	3
1994	6
1995	9
1996	7
1997	8
1998	3
1999	7
2000	6
2001	6
2002	4
2003	4
2004	6
2005	1
2006	7
2007	7
2008	6
2009	10
2010	8
2011	5
2012	7
2013	3
2014	5
2015	6
2016	1
2017	3
2018	3
2019	3
2020	5
2021	3
2022	3
2023	1
2024	3
2025	1
2026	1

1

Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ. Williams JT, et al. Among authors: chavkin c. Pharmacol Rev. 2013 Jan 15;65(1):223-54. doi: 10.1124/pr.112.005942. Print 2013 Jan. Pharmacol Rev. 2013. PMID: 23321159 Free PMC article. Review.

2

Ketamine Pharmacodynamics Entangled: Comment.

Bowdle TA, Sackett N, Strassman R, Murray TF, Jelacic S, Chavkin C. Bowdle TA, et al. Among authors: chavkin c. Anesthesiology. 2022 Dec 1;137(6):747-748. doi: 10.1097/ALN.0000000000004349. Anesthesiology. 2022. PMID: 36095043 No abstract available.

3

Endogenous opioid regulation of hippocampal function.

Simmons ML, Chavkin C. Simmons ML, et al. Among authors: chavkin c. Int Rev Neurobiol. 1996;39:145-96. doi: 10.1016/s0074-7742(08)60666-2. Int Rev Neurobiol. 1996. PMID: 8894847 Review.

4

G Protein Inactivation as a Mechanism for Addiction Treatment.

Neiswanger C, Ruiz MV, Kimball K, Lee JD, Land BB, Berndt A, Chavkin C. Neiswanger C, et al. Among authors: chavkin c. Biol Psychiatry. 2026 Jan 1;99(1):80-90. doi: 10.1016/j.biopsych.2025.03.021. Epub 2025 Apr 4. Biol Psychiatry. 2026. PMID: 40189004 Free PMC article.

5

Dynorphin--still an extraordinarily potent opioid peptide.

Chavkin C. Chavkin C. Mol Pharmacol. 2013 Apr;83(4):729-36. doi: 10.1124/mol.112.083337. Epub 2012 Nov 14. Mol Pharmacol. 2013. PMID: 23152558 Free PMC article. Review.

6

Opioid systems in the dentate gyrus.

Drake CT, Chavkin C, Milner TA. Drake CT, et al. Among authors: chavkin c. Prog Brain Res. 2007;163:245-63. doi: 10.1016/S0079-6123(07)63015-5. Prog Brain Res. 2007. PMID: 17765723 Review.

7

Dynorphin, Dysphoria, and Dependence: the Stress of Addiction.

Chavkin C, Koob GF. Chavkin C, et al. Neuropsychopharmacology. 2016 Jan;41(1):373-4. doi: 10.1038/npp.2015.258. Neuropsychopharmacology. 2016. PMID: 26657953 Free PMC article. Review. No abstract available.

8

Insidious Transmission of a Stress-Related Neuroadaptation.

Steger JS, Land BB, Lemos JC, Chavkin C, Phillips PEM. Steger JS, et al. Among authors: chavkin c. Front Behav Neurosci. 2020 Oct 5;14:564054. doi: 10.3389/fnbeh.2020.564054. eCollection 2020. Front Behav Neurosci. 2020. PMID: 33132859 Free PMC article.

9

C-fos-deficient mouse hippocampal CA3 pyramidal neurons exhibit both enhanced basal and kainic acid-induced excitability.

Jin W, Zhang J, Lou D, Chavkin C, Xu M. Jin W, et al. Among authors: chavkin c. Neurosci Lett. 2002 Oct 18;331(3):151-4. doi: 10.1016/s0304-3940(02)00872-8. Neurosci Lett. 2002. PMID: 12383919

10

Will biased ligands be the opioids of the future?

Ballantyne JC, Chavkin C. Ballantyne JC, et al. Among authors: chavkin c. Pain. 2020 Sep 1;161(9):1945-1948. doi: 10.1097/j.pain.0000000000001913. Pain. 2020. PMID: 32379220 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Results by year